Brief: Cingulate Presents Data For Triple-Release Buspirone Product Candidate Ctx-2103

Cingulate

19/09/2022 11:54

Sept 19 (Reuters) - Cingulate Inc  CING.O :
    * CINGULATE PRESENTS DATA FOR ITS TRIPLE-RELEASE BUSPIRONE
PRODUCT
CANDIDATE: CTX-2103
    * CINGULATE INC - DATA DEMONSTRATED ABILITY OF CTX-2103 TO
DELIVER
A SINGLE ADMINISTRATION OF TRIPLE-RELEASE BUSPIRONE
    * CINGULATE INC - TABLET WAS ALSO ABLE TO DELIVER INTENDED
DOSES
AT THREE TIME POINTS

Source text for Eikon:  ID:nGNX54w48X 
Further company coverage:  CING.O 

 ((Reuters.Briefs@thomsonreuters.com;))